Yttrium Y-90

DB13076ApprovedInvestigationalSmall molecule

Yttrium 90 has been investigated for the treatment of Colon Cancer and Colorectal Cancer.

Chemical structure of Yttrium Y-90
Mechanism
Curator reviewed
Formula / weight
Y · 89.9072 g/mol (avg)
First approval
European Union, 2016
Also known as
Y-90 · Y90 · Yttrium (90 Y) · Yttrium (90Y) · Yttrium Y 90
Brand names
  • Yttriga

Resolves to

Compound
UNII1K8M7UR6O1CAS10098-91-6PubChem104760
Clinical / RWD
ATCV10AA01
Structure
InChIKeyVWQVUPCCIRVNHF-OUBTZVSYSA-NSMILES[90Y]
Targets
P01589IL2RAQ01726MC1RQ12884FAPP08575PTPRC

What you can answer from here — as of August 30, 2026

6Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
46Clinical trialsPhase, status and sponsor resolved per trial
Sign in
1Structured indicationCondition, population, route and combination as fields, not prose
Sign in
10Marketed productsAcross 4 countries and 4 labellers
Sign in
1ATC codeIncluding every combination product, plus 14 drug categories
Sign in
9+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Yttrium Y-90, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In